Medicine preparation waste gas treatment device

Abstract

The utility model provides a medicine preparation waste gas treatment device. The medicine preparation waste gas treatment device comprises a filtering assembly, a cooling assembly and a catalysis piece, the filtering assembly, the cooling assembly and the catalysis assembly are communicated; the cooling assembly comprises a cooling cylinder and a cold water pipe, and the cold water pipe is a spiral pipe body; the catalytic assembly comprises a catalytic tower and a catalyst bed, the catalyst bed is fixed in the catalytic tower, and the catalyst bed is in a honeycomb shape. According to the medicine preparation waste gas treatment device, the spiral cold water pipe is matched with the honeycomb-shaped catalyst bed, so that waste gas can adapt to the reaction temperature of a catalyst, the waste gas is stably catalyzed and oxidized, the waste gas emission standard is met, and the waste gas treatment efficiency is improved.

Description

Technical Field

[0001] This utility model relates to the field of waste gas treatment technology, and in particular to a waste gas treatment device for pharmaceutical preparation. Background Technology

[0002] Waste gas refers to toxic and harmful gases emitted by humans during production and daily life. In particular, waste gases emitted by chemical plants, steel mills, pharmaceutical factories, and oil refineries have strong odors, seriously polluting the environment and affecting human health. The modern pharmaceutical industry inevitably uses large quantities of chemical and biological agents in its production processes, thus generating significant amounts of waste gas.

[0003] The pharmaceutical industry generates a large amount of waste gas during the production process. This waste gas contains a variety of harmful substances, such as volatile organic compounds (VOCs) and particulate matter, which pose serious threats to the environment and human health.

[0004] Currently, waste gas treatment typically employs a combination of physical and chemical methods. On one hand, particulate matter is filtered using filtration components; on the other hand, a catalyst is used to catalyze the oxidation of the waste gas. However, pharmaceutical waste gas exhibits unstable temperatures after filtration, sometimes reaching high levels, making it difficult to match the optimal reaction temperature of the catalyst and resulting in low waste gas treatment efficiency. Utility Model Content

[0005] Based on the above situation, the main purpose of this utility model is to provide a pharmaceutical material processing waste gas treatment device to solve the problem that the temperature of pharmaceutical waste gas is unstable after filtration, and the temperature is too high, making it difficult to match the optimal reaction temperature of the catalyst, resulting in low waste gas treatment efficiency.

[0006] To achieve the above objectives, the technical solution adopted by this utility model is as follows:

[0007] A pharmaceutical material preparation waste gas treatment device includes a filter assembly, a cooling assembly, and a catalytic catalyst;

[0008] The filtration assembly, cooling assembly, and catalytic assembly are connected in series;

[0009] The cooling assembly includes a cooling cylinder and a cold water pipe, wherein the cold water pipe is a spiral-shaped pipe.

[0010] The catalytic assembly includes a catalytic tower and a catalyst bed, the catalyst bed being fixed inside the catalytic tower and having a honeycomb structure.

[0011] Preferably, a second connecting pipe is provided between the cooling cylinder and the catalytic tower;

[0012] An electric valve and a temperature sensor are installed in the middle of the second connecting pipe.

[0013] Preferably, the electric valve is located closer to the cooling cylinder than the temperature sensor.

[0014] Preferably, it also includes an emission assembly, which includes a fan and a flue, a third connecting pipe connecting the flue and the catalytic tower, and the fan being disposed in the middle of the third connecting pipe.

[0015] Preferably, the inside of the flue is fixed with an activated carbon layer.

[0016] Preferably, both the inlet and outlet ends of the cold water pipe extend outside the cooling cylinder.

[0017] The beneficial effects of this utility model are as follows: the catalyst bed is honeycomb-shaped, which allows the cooled flue gas to fully undergo catalytic oxidation reaction after entering the catalytic component, converting harmful gases into harmless gases. In this application, a spiral cooling water pipe and a honeycomb-shaped catalyst bed are used in combination, so that the exhaust gas can be adapted to the catalyst reaction temperature, allowing the exhaust gas to be stably catalytically oxidized, meeting the exhaust gas emission standards, and improving the exhaust gas treatment efficiency.

[0018] Other beneficial effects of this utility model will be explained in detail through the introduction of specific technical features and technical solutions in the specific embodiments. Those skilled in the art should be able to understand the beneficial technical effects brought about by the technical features and technical solutions through the introduction of these technical features and technical solutions. Attached Figure Description

[0019] Figure 1 This is a schematic diagram of the structure of a pharmaceutical material preparation waste gas treatment device according to the present invention.

[0020] Figure 2 This is a cross-sectional view of the cooling component of a pharmaceutical material preparation waste gas treatment device according to this utility model.

[0021] Figure 3 This is a cross-sectional view of the catalytic component of a pharmaceutical material preparation waste gas treatment device according to the present invention.

[0022] Figure 4 This is a cross-sectional view showing the activated carbon layer of a pharmaceutical material preparation waste gas treatment device according to the present invention.

[0023] Explanation of reference numerals in the attached figures:

[0024] 1. Filter assembly; 11. Inlet pipe; 12. First connecting pipe; 2. Cooling assembly; 21. Cooling cylinder; 211. Second connecting pipe; 212. Electric valve; 213. Temperature sensor; 22. Cold water pipe; 3. Catalytic assembly; 31. Catalytic tower; 32. Catalyst bed; 33. Third connecting pipe; 4. Emission assembly; 41. Fan; 42. Flue; 421. Activated carbon layer. Detailed Implementation

[0025] The present invention will now be described based on embodiments, but the present invention is not limited to these embodiments. In the following detailed description of the present invention, some specific details are described in detail, but well-known methods, processes, procedures, and elements are not described in detail in order to avoid obscuring the essence of the present invention.

[0026] Furthermore, those skilled in the art should understand that the accompanying drawings provided herein are for illustrative purposes only and are not necessarily drawn to scale.

[0027] Unless the context explicitly requires it, the words "comprising," "including," and similar terms throughout the specification and claims should be interpreted as encompassing rather than being exclusive or exhaustive; that is, meaning "including but not limited to."

[0028] In the description of this utility model, it should be understood that the terms "first," "second," etc., are used for descriptive purposes only and should not be construed as indicating or implying relative importance. Furthermore, in the description of this utility model, unless otherwise stated, "a plurality of" means two or more.

[0029] Reference Figure 1-3 This utility model provides a pharmaceutical manufacturing waste gas treatment device, including a filter assembly 1, a cooling assembly 2, a catalytic assembly 3, and an emission assembly 4. The filter assembly 1, cooling assembly 2, and catalytic assembly 3 are interconnected. The filter assembly 1 removes particles from the waste gas, the cooling assembly 2 lowers the temperature of the waste gas, and the catalytic assembly 3 can be equipped with a catalytic oxidant to convert the waste gas into harmless substances. The gas converted into harmless substances can be discharged through the emission assembly 4.

[0030] One end of the filter assembly 1 is connected to the pharmaceutical equipment through the air inlet pipe 11 to collect exhaust gas. The internal structure of the filter assembly 1 can be an electrostatic precipitator or a multi-layer filter cotton screen structure. The above structures are all existing technologies and will not be described in detail in this application. The filter assembly 1 is mainly used to remove particles in the exhaust gas so that the exhaust gas can enter the catalytic assembly 3 for better reaction.

[0031] The cooling assembly 2 includes a cooling cylinder 21 and a cold water pipe 22. The cooling cylinder 21 is fixed to the ground by a straight rod and is vertically arranged. The cooling cylinder 21 and the filter assembly 1 are connected by a first connecting pipe 12. The first connecting pipe 12 can discharge the filtered flue gas into the cooling assembly 2. The cold water pipe 22 is a spiral pipe and is fixed in the cooling cylinder 21. The inlet and outlet of the cold water pipe 22 extend to the outside of the cooling cylinder 21. The inlet and outlet of the cold water pipe 22 can be connected to an external circulating refrigeration system, so that the inside of the cooling cylinder 21 can be kept at a low temperature to maintain the cooling effect on the exhaust gas.

[0032] A second connecting pipe 211 is fixed to the upper end of the cooling cylinder 21, and the second connecting pipe 211 is connected to the catalytic assembly 3. The catalytic assembly 3 includes a catalytic tower 31 and a catalyst bed 32. The catalytic tower 31 is connected to the second connecting pipe 211, and the catalyst bed 32 is fixed inside the catalytic tower 31. The catalyst used in the catalytic assembly 3 can be a metal oxide, which is less expensive than precious metal catalysts. The catalyst bed 32 is honeycomb-shaped, which allows the cooled flue gas to fully undergo catalytic oxidation after entering the catalytic assembly 3, converting harmful gases into harmless gases. In this application, a spiral cooling pipe and a honeycomb-shaped catalyst bed 32 are used in combination, so that the exhaust gas can be adapted to the catalyst reaction temperature, allowing the exhaust gas to be stably catalytically oxidized, meeting the exhaust gas emission standards, and improving the exhaust gas treatment efficiency.

[0033] In one embodiment, an electric valve 212 and a temperature sensor 213 are provided in the middle of the second connecting pipe 211. The temperature sensor 213 is connected to the electric valve 212 and is located closer to the cooling cylinder 21 than the electric valve 212. The flue gas discharged through the cooling cylinder 21 can remain in the cooling cylinder 21 and the second connecting pipe 211 under the control of the electric valve 212. The temperature sensor 213 detects that the temperature of the exhaust gas in the second connecting pipe 211 is within a suitable range. The temperature sensor 213 can send a command to the electric valve 212 or manually control the electric valve 212 to open it, so that the flue gas with a suitable temperature enters the catalytic tower 31.

[0034] The emission assembly 4 includes a fan 41 and a flue 42. A third connecting pipe 33 is fixed below the catalytic tower 31, connecting the third connecting pipe 33 and the flue 42. The fan 41 is located in the middle of the third connecting pipe 33. The flue 42 is vertically arranged, allowing the flue gas emitted from the catalytic tower 31 to be discharged through the flue 42. The inside of the flue 42 has an activated carbon layer 421, which further removes residual harmful substances. It should be noted that the top of the flue 42 can be equipped with detection devices such as thermocouples or infrared spectrometers as needed; this will not be elaborated upon in this application.

[0035] The implementation principle of this utility model is as follows: the catalyst bed 32 is honeycomb-shaped, which allows the cooled flue gas to fully undergo catalytic oxidation reaction after entering the catalytic component 3, converting harmful gases into harmless gases. In this application, the spiral cooling water pipe 22 and the honeycomb-shaped catalyst bed 32 are used in combination, so that the exhaust gas can be adapted to the catalyst reaction temperature, allowing the exhaust gas to be stably catalytically oxidized, achieving the exhaust gas emission standards and improving the exhaust gas treatment efficiency.

[0036] Those skilled in the art will understand that, without conflict, the above-mentioned preferred solutions can be freely combined and superimposed.

[0037] It should be understood that the above-described embodiments are merely exemplary and not restrictive. Without departing from the basic principles of this utility model, any obvious or equivalent modifications or substitutions that those skilled in the art can make regarding the above details will be included within the scope of the claims of this utility model.

Claims

1. A pharmaceutical material waste gas treatment device, characterized by, The filter assembly, the cooling assembly and the catalytic assembly are communicated. The cooling assembly comprises a cooling cylinder and a cold water pipe. The cold water pipe is a spiral pipe body. The catalytic assembly comprises a catalytic tower and a catalyst bed.

2. A pharmaceutical material waste gas treatment apparatus according to claim 1, wherein The catalyst bed is fixed in the catalytic tower and is honeycomb-shaped. A second connecting pipe is connected between the cooling cylinder and the catalytic tower.

3. A pharmaceutical material waste gas treatment apparatus according to claim 2, wherein An electric valve and a temperature sensor are arranged in the middle of the second connecting pipe.

4. The pharmaceutical material waste gas treatment apparatus according to claim 1, wherein The electric valve is closer to the cooling cylinder than the temperature sensor.

5. A pharmaceutical material waste gas treatment apparatus according to claim 4, wherein An exhaust assembly is further arranged, which comprises a fan and a smoke pipe.

6. The pharmaceutical material waste gas treatment apparatus according to claim 1, wherein A third connecting pipe is connected between the smoke pipe and the catalytic tower. The fan is arranged in the middle of the third connecting pipe. An activated carbon layer is fixed in the smoke pipe. The water inlet end and the water outlet end of the cold water pipe extend out of the cooling cylinder.

Images